An individualized immune prognostic signature in lung adenocarcinoma

BACKGROUND: Tumor immune infiltration is closely associated with clinical outcome in lung cancer. We aimed to develop an immune signature to improve the prognostic predictions of lung adenocarcinoma (LUAD). METHODS: We applied “Cell type Identification by Estimating Relative Subsets of RNA Transcrip...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Liangdong, Jiang, Gening, Gonzalez-Rivas, Diego, Zhang, Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7206750/
https://www.ncbi.nlm.nih.gov/pubmed/32410884
http://dx.doi.org/10.1186/s12935-020-01237-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7206750/
https://www.ncbi.nlm.nih.gov/pubmed/32410884
http://dx.doi.org/10.1186/s12935-020-01237-4

Ejemplares similares